Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IER3IP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RBM12B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PEX13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUMO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TXNDC9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATMIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CKAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM230 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNIH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF5P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM14A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM267 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RCN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SKA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF1AX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GTPBP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC73 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on